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Background: The United States control program for classical ovine scrapie is based in part on the finding that
infection is typically spread through exposure to shed placentas from infected ewes. Transmission from goats to
sheep is less well described. A suitable rodent model for examining the effect of caprine scrapie isolates in the
ovine host will be useful in the ovine scrapie eradication effort. In this study, we describe the incubation time, brain
lesion profile, glycoform pattern and PrPSc distribution patterns in a well characterized transgenic mouse line
(Tg338) expressing the ovine VRQ prion allele, following inoculation with brain from scrapie infected goats.
Results: First passage incubation times of caprine tissue in Tg338 ovinized mice varied widely but second passage
intervals were shorter and consistent. Vacuolation profiles, glycoform patterns and paraffin-embedded tissue blots
from terminally ill second passage mice derived from sheep or goat inocula were similar. Proteinase K digestion
products of murine tissue were slightly smaller than the original ruminant inocula, a finding consistent with
passage of several ovine strains in previous reports.
Conclusions: These findings demonstrate that Tg338 mice propagate prions of caprine origin and provide a
suitable baseline for examination of samples identified in the expanded US caprine scrapie surveillance program.
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Ovine and caprine scrapie are transmissible spongiform
encephalopathies (TSEs) of small ruminant livestock.
TSEs are also reported in domestic cattle and exotic
zoo-raised bovids (bovine spongiform encephalopathy or
BSE) and in farm-raised and free-ranging cervids
(chronic wasting disease or CWD of deer, elk and
moose). Human TSEs include a varied group of familial,
sporadic, iatrogenic and infectious disorders. Human
variant Creutzfeldt Jakob disease (vCJD) is a novel infec-
tious TSE apparently originating from exposure to infec-
tious bovine tissues [1,2] and transmitted at low rates
through blood transfusion [3]. Although scrapie has not
demonstrated zoonotic potential, the introduction of
vCJD through exposure to domestic animal food pro-
ducts has led to a call for global eradication of all animal
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reproduction in any medium, provided the orTSEs are characterized by accumulation of a relatively
protease resistant isoform (PrPSc) of the normal cellular
prion protein (PrPc), encoded by the PRNP gene [4]. The
transmissible agent, referred to as a prion, is uniquely
proteinaceous [5] and composed largely of PrPSc. In all
TSEs, prions and PrPSc accumulate in the central ner-
vous system but significant accumulation also occurs in
the lymphoid tissue and placenta [6,7] of sheep and
goats with classical scrapie. Classical ovine scrapie is ap-
parently transmitted by oral or mucosal exposure to
prions shed in the placenta, blood and/or milk of
infected postparturient ewes [8]. Susceptibility to infec-
tion with the classical ovine scrapie agent is associated
with the amino acid sequence of the host PrPc [9]. Selec-
tion for relatively resistant breeding stock has the poten-
tial of accelerating eradication of ovine scrapie from
domestic flocks.
Caprine scrapie may originate from exposure to
infected sheep or infected goats. Classical ovine scrapie
is readily transmitted from sheep to domestic goats by
experimental oral challenge with placental tissue [8].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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turition and the use of milk from goats for feeding
orphaned lambs raise the question of whether caprine
scrapie is transmissible to sheep under field conditions
and if so, whether there are strains of caprine scrapie
that result in novel diagnostic or transmission patterns
when passaged in sheep. Large animal experiments to
address these issues in the natural host are expensive
and time consuming, with incubation time measured in
years. The introduction of transgenic mice in which the
murine PRNP gene is replaced by the PRNP gene of the
species of interest has provided an alternative means for
estimating interspecies transmission potential. The pur-
pose of this study was to examine the feasibility of using
the well characterized ovinized mouse strain Tg338 as a




Brain tissue was collected from three domestic goats
(case numbers 3538, 3558 and 30–75) and one reference
domestic sheep (case number 3178) with naturally-
acquired classical scrapie. All four animals had been
identified as scrapie suspect animals based on antemor-
tem detection of PrPSc in rectal mucosal associated
lymphoid tissue using immunohistochemistry. Scrapie
was diagnosed by postmortem detection of PrPSc in the
medulla at the level of the obex.
PRNP genotyping was performed on the 4 donor sam-
ples. The reference sheep 3178 was homozygous for the
wild type ovine allele, encoding alanine at codon 136, ar-
ginine at codon 154, and glutamine at codon 171 (ARQ/
ARQ). This genotype is identified in more than 90% of
the scrapie cases diagnosed in the US [10] and Canada
[11]. The caprine PRNP gene is highly polymorphic
[12,13] and there is no standard nomenclature for nam-
ing alleles. Polymorphisms have been identified on two
haplotypes, differing at codon 240 (encoding proline P
or serine S). Goat 3538 was homozygous for the wild
type allele encoding 240P with no other polymorphisms
on either strand. Goat 30–75 was heterozygous for 2
alleles on the 240P backbone; the wild type allele encod-
ing glycine at codon 127 and an alternative allele encod-
ing serine at that site. Goat 3558 was heterozygous for 2
alleles on the 240P backbone; the wild type allele encod-
ing isoleucine at codon 142 and an alternative allele en-
coding methionine at that site.
Brain homogenates were assessed for relative PrPSc
levels using serial endpoint dilutions in western blot
and ELISA (Figure 1, panels A-D). ELISA testing using
a commercial kit was performed on serial two-fold dilu-
tions of brain homogenate; the coefficient of variation
(CV) for the 24 samples (6 dilutions per homogenatefor each of 3 goats and 1 sheep) ranged from 0 to 0.19,
with 20 of the 24 samples having CV of less than or
equal to 0.1 (data not shown). The last serial dilution
resulting in a detectable signal by either ELISA or west-
ern blot analysis varied from 23 (for goat 3558) to 186
(for goat 3538 and sheep 3178) μg starting wet weight
tissue. Inoculations were performed using a standard
brain homogenate inoculum equivalent to 2 mg starting
wet weight containing 71–99 mg total protein (data not
shown).
Survival curves in bioassay mice
Shown in Figure 2 are the first (P1) and second (P2)
passage survival curves for Tg338 mice inoculated by
the intracerebral route with scrapie isolates derived ei-
ther from the three naturally infected goats (3538,
3558, 30–75) or a naturally infected reference sheep
(3178). Median survival times with 95% confidence
intervals are reported for all isolates in Table 1. P1 sur-
vival curves were relatively prolonged in duration and
variable (median survival time: range, 166–253 dpi),
with limited overlaps between curves produced by the
different isolates. In contrast, P2 survival curves were
considerably less variable and shorter in duration (me-
dian survival times: range, 130–137 dpi). Per isolate,
the median survival time was reduced upon second
passage by 36–116 dpi. Since the P1 survival curve for
the isolate derived from goat 3538 appeared biphasic,
the P1 brain homogenate from two mice, a shorter sur-
vival time mouse (228 dpi) and a longer survival time
mouse (331 dpi), were used in P2 for this caprine scra-
pie sample. A significant difference was not observed
between these two subset P2 survival curves (data not
shown; Wilcoxon Chi-square = 2.1399, P = 0.1453).
Thus, these two data subsets were combined for calcu-
lation of the median survival time reported for this
sample in Table 1.
Western blot analysis
Western blot analysis of brain homogenates from donor
goats (n=3) and sheep (n=1) and bioassay recipient Tg338
mice (n=17 P1, 21 P2 mice) showed the characteristic
banding pattern of proteinase K resistant PrPSc. Representa-
tive data are shown in Figure 3. Ovine and caprine brain
samples co-migrated and were detected with antibodies
binding the carboxyl terminus (mAb F99/97.6.1, residues
221–224) (Figure 3A), the amino terminus (mAb P4, resi-
dues 93–99) (Figure 3B), and the central region (SAF84,
residues 167–172) (data not shown). For samples derived
from all Tg338 mice, the unglycosylated band migrated
with an apparent molecular weight approximately 1.5–
2 kDa lower than the samples from sheep and goat donor
tissues. Epitope mapping demonstrated the loss of the
epitope for amino terminus mAb P4 (Figure 3B) but
Figure 1 Relative levels of PrPSc in brain homogenate from donor animals. Serial two-fold dilutions of brain homogenate from goat
3538 (A), 3558 (B), 30–75 (C) and reference sheep 3178 (D) were analyzed by western blot analysis and ELISA. Absorbance (A450) results
from ELISA (−•-) are shown on the left y axis and density of the diglycosylated band determined from scans of western blot (vertical bars
and inset image) on the right y axis. Starting wet weight equivalents per ELISA well or Western blot lane are shown on the x axis. Cut
off limit for the ELISA (−−————————) was determined from the manufacturer’s negative control sample.
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(Figure 3A). There was no evidence of a 14 kDa carboxyl
fragment when using mAb SAF84 [14].
The possibility that the apparent shift in the PK cleav-
age site on mouse passage was due to replication in per-
ipheral tissues and subsequent dissemination to the
brain was addressed by intraperitoneal challenge of mice
with the reference sheep homogenate. Electrophoretic
profiles of PrPSc from the brain tissue of P1 (Figure 4,
lane 4) or P2 (Figure 4, lane 2) mice inoculated with the
reference sheep brain homogenate (Figure 4, lanes 1, 3,
5 and 7) by the IC route (Figure 4, lanes 2 and 4) were
similar to those from the brain of P1 mice inoculated by
the intraperitoneal (IP) route (Figure 4, lane 6), demon-
strating co-migration of brain-derived PrPSc from mur-
ine samples regardless of route of inoculation. PrPSc
bands from Tg338 spleen samples (Figure 4, lane 8) had
a slightly slower migration rate than those from brainsamples, ruling out peripheral amplification as a mech-
anism for the profile shift.
Glycoform analysis
Glycoform analysis was performed on PK-digested
homogenates of P2 Tg338 brain from each of the 4
inoculum groups (1 reference sheep and 3 goats with
naturally occurring scrapie). Western blots were
scanned and the percent of the total density repre-
sented in each of the 3 PrPSc bands was plotted. Al-
though identical wet weight equivalents (300 μg) of
each P2 mouse brain homogenate were loaded, the
relative amount of PrPSc in each sample slightly var-
ied among mice (Additional file 1). The relative
amounts of the PrPSc bands were diglycosylated >
monoglycosylated > unglycosylated (Figure 5 and
Additional file 2). Notwithstanding minor differences
in relative band densities, graphic display on a tri-
Figure 2 Kaplan-Meier survival curves for Tg338 mice
inoculated with different isolates of small ruminant scrapie.
Shown are the survival curves for first (upper panel) and second
(lower panel) intracerebral passage in Tg338 mice including
censored data. Scrapie isolates were derived from the brain of three
clinical goats (broken lines: 3538, 3558 and 30–75) and a reference
sheep (solid blue line: 3178). Note the reductions in survival times
per isolate (days post-inoculation, dpi) as well as the reduction in
survival time variation between isolates upon second passage. The
color line code for each isolate source is indicated in the key.
Table 1 Inoculum groups and median survival times after
serial intracerebral passage in Tg338 mice










(n, c) (dpi) (dpi)
goat 30–75 P1 10, 0 166.0 166.0–180.0
3538 10, 0 253.0 199.0–331.0
3558 9, 0 253.0 199.0–280.0
sheep 3178 7, 3 241.0 180.0–257.0
goat 30–75 P2 11, 3 130.0 125.0–130.0
3538 22, 2 137.0 133.0–137.0
3558 9, 0 137.0 133.0–139.0
sheep 3178 19, 0 135.0 129.0–136.0
1 Kaplan-Meier product-limit estimation of survival functions for n non-censored
and c censored recipients per isolate.
295% lower and upper confidence limits (UCL, LCL) were determined using the
log(−log) transform.
Figure 3 Western blot analysis of brain from small ruminants
and P2 Tg338 mice bioassay recipients. Western blot analysis of
brain from goat 3538 (lane 1, 150 μg starting wet weight brain ),
goat 3558 (lane 3, 250 μg ), goat 30–75 (lane 5, 250 μg) and sheep
3178 (lane 7, 350 μg), and brain from P2 mice from each of those 4
inoculum groups (lanes 2, 4 , 6 and 8, respectively, loaded with
60–100 μg brain) after digestion with proteinase K (50 μg/ml final
concentration for goats and sheep, 100 μg/ml final concentration for
mice) and detection with mAb F99/97.6.1, binding a carboxyl
epitope (A) or mAb P4, binding an amino terminal epitope (B). Lane
9 contains brain (300 μg) from an age-matched uninoculated Tg338
mouse, homogenized and treated with proteinase K as described for
tissue from P1 and P2 mice. Molecular mass markers are shown on
the left.
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isolates (Figure 5).
Histologic scoring of vacuolization by brain region of
Tg338 mice
Distribution and severity of vacuolization was assessed
in P2 Tg338 mice from each of the 4 inoculum groups.
Twelve regions (9 grey matter, 3 white matter) [15] of
each second passage Tg338 mouse and non-inoculated,
age-matched mice were scored for vacuolization by a
pathologist (TRS) without knowledge of inoculum
group. Vacuolization was not observed (score = 0) within
any of the twelve brain regions of non-inoculated miceexcept for within G2 where a score of “1” was recorded
for one mouse; the mean (± standard error) score for re-
gion G2 in non-inoculated mice was thus 0.125± 0.354
(n= 8 mice), which is not significantly different than a
score of 0.
Mean vacuolization scores and variation for P2 Tg338
mice are shown in Figure 6. The mean vacuolization
scores in all inoculum groups were significantly greater
than 0 in brain regions G1, G4, G5, G7, and W2 and
W3, but were not significantly different from zero in
Figure 4 Co-migration of brain homogenates from Tg338 mice
inoculated by the intracerebral route or the intraperitoneal
route. Brain homogenate from sheep 3178 (lanes 1, 3, 5 and 7,
350 μg starting wet weight per lane) and Tg338 mice (100 μg
starting wet weight per lane) inoculated by the intracerebral route
and assayed at passage 2 (lane 2) or passage 1 (lane 4). The same
homogenate was inoculated intraperitoneally in Tg338 mice; first
passage brain (lane 6) and spleen (lane 8) homogenates were
assayed. Lane 9, brain homogenate (200 μg starting wet weight)
from uninoculated Tg338 mouse. All tissues were digested with
proteinase K (100 μg /ml final concentration for murine tissues and
50 μg/ml final concentration for ovine tissues). Filter was probed
with mAb F99/97.6.1. Molecular mass markers are shown on the left.
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scores in region G3 were the most variable: the mean
vacuolization score was significantly increased for
groups derived from sheep 3178 (n = 10) and goat 3538
(n = 11) but not for goats 3558 (n = 4) and 30–75 (n = 5).
PET blots
Paraffin embedded tissue (PET) blot analysis was per-
formed on brain sections from one mouse in each P1 in-
oculum group and 4 to 9 mice in each of the P2 groups.Figure 5 Glycoform analysis of PrPSc in Tg338 mice inoculated
with different isolates of small ruminant scrapie. Relative
densities of unglycosylated, monoglycosylated and diglycosylated
forms of PrPSc bands were obtained for each P2 mouse brain using
an image analyzer. Green circle – inoculum group 3558; red circle –
inoculum group 3538; black circle – inoculum group 30–75; blue
circle – inoculum group 3178.Representative data are shown in Figure 7. No labeling
was detected in brains from negative controls
(Figure 7C) or in samples labeled with an isotype control
antibody (data not shown). PK-resistant PrP was visible
at all 4 anatomic levels in sections from infected mice,
with dense labeling in the striatum, ventral pallidum,
claustrum, insular cortex, paraterminal body and cingu-
lated cortex at level 1, the thalamus and hypothalamus
at level 2, the superior colliculus and midbrain at level 3
and deep cerebellar nuclei and medulla at level 4. There
was no evidence of species-specific discriminatory label-
ing and no significant variation within the 3 caprine
scrapie groups.
Discussion
Bioassay of tissues from scrapie infected sheep and goats
demonstrated the transmissible nature of the disorder
and the novel characteristics of the infectious agent well
before the introduction of the prion hypothesis [16,17].
Oral and parenteral challenge demonstrated the suscep-
tibility of goats to ovine scrapie [18-20]. Reciprocal stud-
ies examining the susceptibility of sheep to caprine
scrapie are less well described. Studies in the natural ru-
minant host are limited by the prolonged incubation
time and the expense of housing large animals in bio-
containment. Transgenic mice expressing a PRNP gene
from a species of interest are a suitable surrogate host
for some studies of prion disease in humans, cattle,
sheep and deer [15,21-27]. Considerable variation is
noted among transgenic strains, however, with differ-
ences in outcome associated with route of inoculation
[28,29], transgene sequence of the regulatory and coding
regions of PRNP [30], and transgene expression level
[31]. The murine Tg338 line expresses the ovine PRNP
VRQ allele under the ovine PRNP promotor with over-
expression of PrPc in the central nervous system and
lymphoreticular system [29], sites of PrPSc accumulation
in sheep and goats. This transgenic mouse line has been
useful in characterizing atypical (Nor98) [32,33] and
classical scrapie in sheep of various genotypes [34,35].
Several ovine isolates have been further characterized by
serial passage to identify candidate classical scrapie
strains differing in biochemical or clinical profiles in
Tg338 mice [36,37]. In this study, we examined the use
of Tg338 mice as a surrogate for characterizing caprine
scrapie bioassayed in the ovine host. We examined incu-
bation time, neuropathological phenotype, glycoform
profile, and proteinase K cleavage pattern following pri-
mary and secondary passage of brain homogenates from
three goats with naturally acquired scrapie. Brain tissue
from a sheep homozygous for the PRNP ARQ allele was
used as a reference ovine scrapie case.
Incubation times for all 4 inoculum groups were pro-
longed and variable upon primary passage to Tg338
Figure 6 Histological vacuole scores by brain region for small
ruminant scrapie in P2 Tg338 mice. Shown are the mean
vacuolization scores with standard errors by Tg338 mouse brain
region for scrapie isolates derived from the brain of three
clinical goats and a reference sheep. Each isolate source case
number is indicated to the right in each panel. Note the similar
regional pattern of grey (G) and white (W) matter vacuole
scores induced by goat and sheep-derived scrapie. G1, dorsal
medulla nuclei; G2, cerebellar cortex of the folia including the
granular layer adjacent to the fourth ventricle; G3, cortex of the
superior colliculus; G4, hypothalamus; G5, thalamus; G6,
hippocampus; G7, septal nuclei of the paraterminal body; G8,
cerebral cortex (at the level of G4 and G5); G9, cerebral cortex
(at the level of G7); W1, cerebellar white matter, W2,
tegmentum; and W3, pyramidal tract.
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Western blot titer. The sample from goat 3538 showed
the widest variation in survival time on primary passage,
with insidious onset at as early as 199 days and clinical
signs of ataxia, weight loss and kyphosis by 206 days;
survival times in some mice in this group exceeded
300 days. Mice were euthanized at 199–228 days (n = 3
short incubation), at 253–263 days (n = 4 mid-range in-
cubation), and at greater than 331 days (n = 3 long incu-
bation). Subpassage of samples from mice in the short
(228 days) and long (331 days) incubation groups
resulted in shorter incubation periods and mean survival
times with no significant difference between the short
and long incubation sample recipients (137 +/−2 and
135 +/−5 respectively); likewise, there was no significant
difference among the groups of P2 mice from the other
inocula.
Several phenotypes have been described following pas-
sage of tissue from scrapie infected sheep to Tg338 mice.
Notably, differences in incubation time on primary and
secondary passage associated with differences in electro-
phoretic profiles have been described [36,38], particu-
larly in sheep with alleles occurring on the ARQ
haplotype. These cases have been reported as homozy-
gous for alleles encoding ARQ at codons 136, 154 and
171, and the effect of other polymorphisms (nonsynon-
ymous changes at codon 141 or 241 for instance, on the
ARQ backbone in donor sheep) has not been deter-
mined. Multiple electrophoretic patterns arising from a
single ovine homogenate occur as individual or mixed
profiles, even when this variation was not noted in the
original ovine sample [38]. In our study, the electrophor-
etic profiles from all murine samples showed only a fast
migrating unglycosylated band corresponding to a re-
duction of ~1.5 to 2 kDa in apparent molecular mass
when compared to the ruminant derived samples. The
shift in PK cleavage site was confirmed by marked re-
duction of reactivity by mAb P4, which recognizes an
epitope at ovine residues 93–99. Western blot analysis
with antibody SAF84 showed no evidence of a 14 kDa
band, ruling out a strain CH1641 pattern [14]. The pat-
tern of prolonged incubation associated with reduced
apparent molecular weight product in Western blot is
consistent with ARQ isolates characterized by Thackray
et al. [34,36], Beck et al. [38], and Tixador et al. [39].
Our observation was not based on an inherent charac-
teristic of the Tg338 mouse line or our methods, as sam-
ples from mice infected with VRQ ovine tissues migrate
at ~21 kDa (data not shown).
PET blots, glycoform analysis, and lesion profiles of
the Tg338 samples derived from caprine brain inocula-
tion were remarkably consistent. The marked uniformity
in survival time following secondary passage and the
consistent patterns in PET blot, glycoform analysis and
Figure 7 Distribution of PK-resistant PrP labeling of PET blots. Shown is the neuroanatomic distribution of PrPSc at 4 different brain
levels of P2 Tg338 mice representing inoculum groups 30–75 (A) and 3178 (B), and an age-matched uninoculated control group mouse
(C). Brain sections were dissected at the levels of frontal cortex (level 1), hypothalamus (level 2), hippocampus (level 3) and cerebellum-
medulla (level 4). Blots were probed with mAb F99/97.6.1. VP, ventral pallidum; HT, hypothalamus; MHN, medial hypothalamic nucleus;
HN, medial habenular nucleus; NM, nucleus mammillaris; NR, nucleus rubor; SN, substantia nigra; NCG, nucleus corporis geniculati; DCN, deep
cerebellar nuclei; M, medulla.
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derived from separate herds, represent a single strain
with characteristics of a predominant US ovine scrapie
strain. This finding is not surprising; scrapie appears to
have been introduced into the US in sheep and is
observed almost exclusively in ARQ homozygous sheep.
Subsequent spread to goats is reported only rarely and
there may be a limited number of caprine scrapie strains
in the population. The US will expand caprine scrapie
surveillance over the next 3 years as ovine scrapie nears
eradication; as additional samples from goats are identi-
fied, monitoring of caprine scrapie strains in the US
using biochemical methods and bioassay in Tg338 mice
should be useful in identifying any additional strains.
Conclusions
The Tg338 mouse strain expressing the VRQ allele of
the ovine PRNP gene is useful in detection and analysis
of ovine prions. In this study, this murine strain was
found to propagate prions following intracerebral inocu-
lation with brain homogenates from goats with naturally
occurring scrapie. The electrophoretic profile and incu-
bation time on secondary passage were similar to those
observed by passage of ARQ homozygous sheep. The
high attack rate and uniform findings on PET blot, gly-
coform analysis and lesion profile provide a suitable
baseline for examination of caprine samples identified in
the expanded US caprine scrapie surveillance program.Methods
Animals and PRNP genotyping
The Washington State University and University of Wash-
ington Institutional Animal Care and Use Committees
granted approval for the study before it was conducted,
under agreements 3811, 3815 and 1640. Breeding pairs of
transgenic Tg338 mice were kindly provided by Hubert
Laude and held in a breeding colony at the University of
Washington. The presence of the transgene was confirmed
by DNA analysis of tail snips.
Scrapie infected goats and sheep were diagnosed by
antemortem analysis of rectal mucosal associated lymph-
oid tissue [40] or post mortem analysis of brain and ret-
ropharyngeal lymph node for evidence of PrPSc deposits
detected by monoclonal antibody immunohistochemistry
[41]. Donor tissue was collected from three domestic
mixed breed goats (case numbers 3558, 3538, and 30–
75) and one reference sheep (case number 3178). The
animals were acquired from separate flocks, although
30-75 and 3538 were born at the same facility. Postmor-
tem confirmation was performed at the National Veter-
inary Services Laboratory, USDA, Ames IA, USA, using
immunohistochemistry analysis of brain using monoclo-
nal antibody (mAb) F99/97.6.1.
Diploid PRNP genotypes were determined by polymer-
ase chain reaction amplification of the open reading
frame followed by DNA sequence analysis of both
strands using standard methods [12,42].
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Brain tissue from the three goats with naturally acquired
scrapie and the reference sheep with classical ovine scra-
pie were prepared as 10% (w/v) homogenates in normal
saline. Relative titer of each homogenate was estimated
from serial dilution and endpoint titration using a com-
mercial enzyme linked immunosorbent assay and west-
ern blot analysis as described below. Total protein levels
varied slightly among the inocula: 2 mg starting wet
weight tissue yielded 76 (goat 3538), 71 (goat 3558), 85
(goat 30–75) and 99 (sheep 3178) μg total protein as
determined by BCA protein assay. Passage 1 (P1) Tg338
mice were inoculated with 20 μl of 10% (w/v) sheep or
goat brain homogenate (2 mg starting wet weight tissue)
by the intracerebral route in the right parietal lobe. Ser-
ial passage of murine brain (passage 2, P2) was per-
formed using 20 μl of a 10% (w/v) homogenate of brain
from clinically affected P1 mice administered by the
intracerebral route as above. An additional group of
mice was inoculated intraperitoneally with brain hom-
ogenate from sheep 3178 using 2 mg starting wet weight
tissue in a final volume of 200 μl. Inoculated animals
and age matched uninoculated controls were monitored
daily for appearance of clinical signs suggestive of scra-
pie (weight loss, lethargy and kyphosis) and culled at ter-
minal disease. Brain and spleen were collected from
mice at necropsy. Samples were fixed in 10% buffered
formalin or frozen at–20C for western blot analysis.
Incubation time
Survival time following intracerebral challenge with
brain homogenates from goats or sheep (P1) or mouse
(P2) was recorded as days post-inoculation (dpi). Recipi-
ent animals terminated for reasons other than clinical
scrapie disease were considered censored data. The
survival function of each scrapie isolate was deter-
mined using the Kaplan-Meier product-limit estimation
method (LIFETEST procedure, SAS for Windows ver-
sion 9.2; SAS Institute Inc., Cary, NC, USA). Median
survival times with 95% confidence limits were deter-
mined by the log(−log) method.
Relative PrPSc levels in goat and sheep inoculum
Relative amounts of PrPSc in brain homogenates from
three goats and one reference sheep with scrapie were
determined by serial endpoint dilution followed by en-
zyme linked immunosorbent assay and Western blot
analysis of paired samples. Aliquots of the 10% hom-
ogenate of sheep or goat tissue prepared for inoculation
were adjusted with 2 volumes of lysis buffer (0.5%
deoxycholic acid, 0.5% NP-40, 10 mM Tris–HCl, pH
7.5) using a table top homogenizer (Fastprep, Thermo
Electron Co., Waltham, MA, USA). Preliminary assays
demonstrated that the use of this lysis buffer did notaffect ELISA readings (data not shown) and the initial
dilution in lysis buffer provided a homogeneous mixture
suitable for aliquoting into paired samples for ELISA
and Western blot. Additional serial two fold dilutions
were prepared in lysis buffer and assayed in duplicate
using a commercially available PrPSc detection kit
(ELISA) (HerdCheck Scrapie-BSE Antigen Test, IDEXX
Laboratories, Westbrook, ME, USA). Mean absorbance
values (A450) were plotted against starting wet weight
equivalents of brain. The cutoff value was determined
using the internal standard provided in the kit.
Western blot analysis
PrPSc was detected by Western blot assay as described
previously [41-43] with minor modifications. Aliquots of
the 10% (w/v) brain homogenates from sheep, goats, or
mice serially diluted in lysis buffer for ELISA (above) were
assayed by Western blot. Homogenates were incubated
with proteinase K (PK) at 100 μg/mL final concentration
at 37C for 90 min for murine homogenates and 50 μg/mL
final concentration at 37C for 60 min for ovine and cap-
rine homogenates. For the endpoint titration of sheep and
goat inocula, the starting 10% homogenate in PBS was
adjusted with two volumes of lysis buffer and treated with
proteinase K (PK) at 50 μg/mL final concentration at 37C
for 60 min. Serial two fold dilutions were prepared in lysis
buffer, combined with sample loading buffer (NuPage,
Invitrogen, Carlsbad, CA, USA), and loaded onto 12-well
12% Nu-PAGE Bis-Tris gels (Invitrogen). Starting wet
weight equivalents for titration were 750 μg for ovine and
caprine tissues. Murine tissues for glycoform analysis were
assayed at 300 μg per lane. After electrophoresis, proteins
were transferred onto polyvinylidene fluoride (PVDF)
membranes (Millipore, Billerica, MA, USA), blocked with
commercial casein blocker (Pierce, Rockford, IL, USA)
and incubated with primary mAb F99/97.6.1 (3.5 μg/mL;
O’Rourke et al., 2000), mAb P4 (0.2 μg/ml, R-BioPharm
AG, Marshall, MI, USA) or mAb SAF84 (0.2 μg/ml, Cay-
man Chemical, Ann Arbor, MI, USA) followed by incuba-
tion with a peroxidase labeled goat anti-mouse IgG1
secondary Ab (Southern Biotech, Birmingham, AL, USA;
1:5,000, for detection of mAb F99/97.6.1) or a peroxidase
labeled F(ab’)2 fraction of goat anti-mouse IgG2 (KPL,
Gaithersburg, MD, USA, 1:20,000 for detection of mAb
P4 and SAF84. Bound antibody was detected by chemilu-
minescence (Amersham ECL, GE healthcare, Piscataway,
NJ, USA). Membranes were exposed to radiographic films
(Kodak BioMax Chemiluminescence Films, Rochester,
NY) for exposure times of 1–10 min. Digital images of the
radiographic films were obtained with an Alpha Innotec
image analyzer (Alpha Innotech Corp, San Leandro, CA,
USA) and saved in tiff file format. Density of the diglyco-
sylated band was plotted against starting wet weight of
tissue to estimate relative endpoints.
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Brain tissues of 20 inoculated mice (five from each
donor group) were selected for glycoform analysis and
tested in three independent western blot assays. For each
sample, triplicate aliquots of 50 μl brain homogenate
were incubated with PK (100 μg/mL final concentration)
at 37C for 90 min. Aliquots equivalent to 300 μg wet
brain weight equivalents were loaded into individual
lanes of 12-well 12% polyacrylamide gels and analyzed
by western blot assay as described above, using mAb
F99/97.6.1. Digital images of the radiographic films were
obtained with an Alpha Innotec image analyzer and
saved in tiff file format. These files were analyzed with
AlphaEaseFC software Version 4.0 to identify the relative
densities of unglycosylated, monoglycosylated and digly-
cosylated forms of PrPSc. For each group of mice, mean
density of each band was plotted into Tri-plot Excel tem-
plate. The tri-plot excel template was downloaded from
http://www.lboro.ac.uk/research/phys-geog/tri-plot [44].
Histopathology
Formalin fixed brains were processed routinely and sec-
tioned at 5 μm for hematoxylin and eosin staining. Tissues
were analyzed for vacuolation profile using standard meth-
ods as described [15]. Lesion severity was quantitated as
described [45]. Briefly, scores were assigned on a scale of 0
to 5 for specific neuroanatomic areas based on the intensity
of the vacuolation. Regions scored were G1, dorsal medulla
nuclei; G2, cerebellar cortex of the folia including the
granular layer, adjacent to the fourth ventricle; G3, cortex
of the superior colliculus; G4, hypothalamus; G5, thalamus;
G6, hippocampus; G7, septal nuclei of the paraterminal
body; G8, cerebral cortex (at the level of G4 and G5); and
G9, cerebral cortex (at the level of G7). In addition, three
white matter areas were scored; W1, cerebellar white mat-
ter, W2, tegmentum, and W3, pyramidal tract. Regions
were assigned 0 if vacuolation was similar to that observed
in negative control mice; 1 for regions with a few unevenly
scattered vacuoles, 2 for regions with a few evenly scattered
vacuoles, 3 for regions with a moderate number of evenly
scattered vacuoles, 4 for regions with many vacuoles, in-
cluding some confluence, and 5 for regions with dense
vacuolation with most of the field confluent. This evalu-
ation was done by examination of the entire region on 20X.
PET blots
Regional distribution and intensity of PrPSc labeling in P2
Tg338 mouse brains were evaluated in paraffin embedded
tissue blots. The brain sections were dissected at the levels
of frontal cortex (level 1), hypothalamus (level 2), hippo-
campus (level 3) and cerebellum-medulla (level 4) and
probed with mAb F99/97.6.1 as described [46-48], with
minor modifications [49]. Eight P2 scrapie inoculated
Tg338 mice, including 2 from each inoculum group and2 age-matched uninoculated negative control mice, were
evaluated as described [48].
Additional files
Additional file 1: Brain tissue from 20 Tg338 passage 2 mice (five
from each sheep- or goat-inoculated P1 donor) were selected for
western blot assay and glycoform analysis. Three hundred μg wet
brain weight equivalent volumes of each of the mouse brain were
digested with proteinase K and loaded into SDS-PAGE gels followed by
western blot assay using mAb F99/97.6.1 and chemiluminescent imaging.
Films (representative film shown in Additional File 1) were used to obtain
relative densities of un-, mono- and di-glycosylated forms of PrPSc bands
for glycoform analysis.
Additional file 2: Glycoform patterns of PrPSc from 3 goats and a
reference sheep with naturally occurring scrapie and from Tg338
mice from each inoculum group.
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